<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>FGF-2, a potent multifunctional and neurotrophic growth factor, is widely expressed in the brain and upregulated in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Previous studies have shown that intraventricularly or systemically administered FGF-2 reduces the size of cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Whether endogenous FGF-2 is beneficial for the outcome of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> has not been investigated </plain></SENT>
<SENT sid="3" pm="."><plain>We have used mice with a null mutation of the fgf2 gene to explore the relevance of endogenous FGF-2 in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was produced by occlusion of the middle cerebral artery (MCAO) </plain></SENT>
<SENT sid="5" pm="."><plain>We found a 75% increase in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in fgf2 knock-out mice versus <z:mp ids='MP_0002169'>wild type</z:mp> littermates (P &lt; 0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>This difference in the extent of ischemic damage was observed after 24 h, and correlated with decreased viability in fgf2 mutant mice following <z:chebi fb="70" ids="34342">MCA</z:chebi> occlusion </plain></SENT>
<SENT sid="7" pm="."><plain>Increased <z:mpath ids='MPATH_124'>infarct</z:mpath> volume in fgf2 null mice was associated with a loss of induction in hippocampal BDNF and trkB <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression </plain></SENT>
<SENT sid="8" pm="."><plain>These findings indicate that signaling through trkB may contribute to ameliorating brain damage following <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and that bdnf and trkB may be target genes of FGF-2 </plain></SENT>
<SENT sid="9" pm="."><plain>Together, our data provide the first evidence that endogenous FGF-2 is important in coping with ischemic brain damage suggesting fgf2 as one crucial target gene for new therapeutic strategies in <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> </plain></SENT>
</text></document>